Stifel Financial Corp Can Fite Bio Pharma Ltd. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
BUY
$1.8 - $2.92 $21,600 - $35,040
12,000 New
12,000 $30,000

Others Institutions Holding CANF

# of Institutions
2
Shares Held
1.1K
Call Options Held
0
Put Options Held
0
View Full List

About Can-Fite BioPharma Ltd.

CANF Quotes by TradingView
  • Ticker CANF
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,191,500
  • Market Cap $54.7M
  • Description
  • Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...
More about CANF
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email